Research progress of nanovaccine in anti-tumor immunotherapy

Overview of attention for article published in Frontiers in oncology, August 2023

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 4 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 18,661 followers.

RT @FrontOncology: New research: Research progress of nanovaccine in anti-tumor immunotherapy: Tumor vaccines aim to activate dormant or un…

03 Sep 2023

Reply Repost Favourite

New research: Research progress of nanovaccine in anti-tumor immunotherapy: Tumor vaccines aim to activate dormant or unresponsive tumor-specific T lymphocytes by using tumor-specific or tumor-associated antigens, thus enhancing the body’s… #oncology https

02 Sep 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.